Steve Hughes

1.1k total citations
17 papers, 369 citations indexed

About

Steve Hughes is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Steve Hughes has authored 17 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Steve Hughes's work include Lipoproteins and Cardiovascular Health (4 papers), Lipid metabolism and disorders (3 papers) and Multiple Sclerosis Research Studies (2 papers). Steve Hughes is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Lipid metabolism and disorders (3 papers) and Multiple Sclerosis Research Studies (2 papers). Steve Hughes collaborates with scholars based in United States, United Kingdom and Canada. Steve Hughes's co-authors include Brett P. Monia, Ray Gani, Merrill D. Benson, Shuling Guo, Elizabeth J. Ackermann, Luis Alvarado, Sheri Booten, David O. Bates, John Kerrigan and Gavin Giovannoni and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Steve Hughes

17 papers receiving 355 citations

Peers

Steve Hughes
Chatchawin Assanasen United States
Benedetta Chiodini Belgium
Peter Benöhr Germany
Danielle Crawley United Kingdom
Laïla Zahed Lebanon
Julie Huang United States
Melinda Zsuzsanna Szabó Hungary
R Rapisarda Italy
Nitya Nathwani United States
Manabu Narisawa Japan
Chatchawin Assanasen United States
Steve Hughes
Citations per year, relative to Steve Hughes Steve Hughes (= 1×) peers Chatchawin Assanasen

Countries citing papers authored by Steve Hughes

Since Specialization
Citations

This map shows the geographic impact of Steve Hughes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Hughes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Hughes more than expected).

Fields of papers citing papers by Steve Hughes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Hughes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Hughes. The network helps show where Steve Hughes may publish in the future.

Co-authorship network of co-authors of Steve Hughes

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Hughes. A scholar is included among the top collaborators of Steve Hughes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Hughes. Steve Hughes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yu, Hailong, Michael D. Shields, Michael W. Crowder, et al.. (2022). Restoring ornithine transcarbamylase (OTC) activity in an OTC‐deficient mouse model using LUNAR‐OTC mRNA. SHILAP Revista de lepidopterología. 2(2). 11 indexed citations
2.
Alexander, Veronica J., Andrés Digenio, Shuting Xia, et al.. (2018). INHIBITION OF APOLIPOPROTEIN C-III WITH GALNAC CONJUGATED ANTISENSE DRUG POTENTLY LOWERS FASTING SERUM APOLIPOPROTEIN C-III AND TRIGLYCERIDE LEVELS IN HEALTHY VOLUNTEERS WITH ELEVATED TRIGLYCERIDES. Journal of the American College of Cardiology. 71(11). A1724–A1724. 13 indexed citations
3.
Brealey, Noushin, et al.. (2018). Hair analysis to monitor adherence to prescribed chronic inhaler drug therapy in patients with asthma or COPD. Pulmonary Pharmacology & Therapeutics. 51. 59–64. 22 indexed citations
4.
Maurer, Mathew S., Stephen B. Heitner, Brian Drachman, et al.. (2018). INOTERSEN IMPROVES QUALITY OF LIFE IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS WITH POLYNEUROPATHY AND CARDIOMYOPATHY: RESULTS OF THE PHASE 3 STUDY NEURO-TTR. Journal of the American College of Cardiology. 71(11). A658–A658. 5 indexed citations
5.
McCaleb, Michael L., et al.. (2018). Pharmacodynamic efficacy of IONIS-FB-LRX, a complement factor B antisense oligonucleotide, in a phase 1 clinical study. Molecular Immunology. 102. 187–188. 2 indexed citations
6.
McCaleb, Michael L., Jason D. Lickliter, Eugene Schneider, et al.. (2018). Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-LRX) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study. Blood. 132(Supplement 1). 3634–3634. 12 indexed citations
7.
McCaleb, Michael L., Tamar R. Grossman, Peter Adamson, et al.. (2017). Systemic Pharmacodynamic Efficacy of a Complement Factor B Antisense Oligonucleotide in Preclinical and Phase 1 Clinical Studies. Investigative Ophthalmology & Visual Science. 58(8). 1952–1952. 5 indexed citations
8.
Gaudet, Daniel, Dirk Blom, Éric Bruckert, et al.. (2017). Familial Chylomicronemia Syndrome (FCS) Patients Recruited to the APPROACH Trial of Volanesorsen Therapy are Representative of Subjects with FCS. Journal of clinical lipidology. 11(3). 817–818. 1 indexed citations
9.
Gouni‐Berthold, Ioanna, Veronica J. Alexander, Andrés Digenio, et al.. (2017). Apolipoprotein C-III Inhibition With Volanesorsen in Patients With Hypertriglyceridemia (COMPASS): A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of clinical lipidology. 11(3). 794–795. 26 indexed citations
10.
11.
Gaudet, Daniel, Veronica J. Alexander, Diane Brisson, et al.. (2014). An Antisense Inhibitor of Apolipoprotein C-III Substantially Decreases Fasting Apolipoprotein C-III and Triglyceride Levels in LPL Deficiency. Journal of clinical lipidology. 8(3). 353–354. 2 indexed citations
12.
Noveck, Robert J., Erik S.G. Stroes, JoAnn Flaim, et al.. (2014). Effects of an Antisense Oligonucleotide Inhibitor of C‐Reactive Protein Synthesis on the Endotoxin Challenge Response in Healthy Human Male Volunteers. Journal of the American Heart Association. 3(4). 38 indexed citations
13.
Viney, N., Mark Graham, Rosanne M. Crooke, Steve Hughes, & W. S. Singleton. (2013). Abstract 14196: Evaluation of Isis Apo(a)Rx, an Antisense Inhibitor to Apolipoprotein(a), in Healthy Volunteers. Circulation. 128. 5 indexed citations
14.
Ackermann, Elizabeth J., Shuling Guo, Sheri Booten, et al.. (2012). Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid. 19(sup1). 43–44. 112 indexed citations
15.
16.
Gani, Ray, Richard M. Nixon, Steve Hughes, & Christopher Jackson. (2007). Estimating the rates of disability progression in people with active relapsing-remitting multiple sclerosis. Journal of Medical Economics. 10(2). 79–89. 7 indexed citations
17.
Johnsen, Sigurd, Steve Hughes, Roger Bullock, & Ian Hindmarch. (2003). Prediction of the Rate of Decline in Cognitive Function in Alzheimer’s Disease: A Model Based on Simple Demographic Data and Widely Used Rating Scales. Dementia and Geriatric Cognitive Disorders. 16(4). 276–282. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chatchawin Assanasen Breakdown of academic impact, for papers by Benedetta Chiodini Breakdown of academic impact, for papers by Peter Benöhr Breakdown of academic impact, for papers by Danielle Crawley Breakdown of academic impact, for papers by Laïla Zahed Breakdown of academic impact, for papers by Julie Huang Breakdown of academic impact, for papers by Melinda Zsuzsanna Szabó Breakdown of academic impact, for papers by R Rapisarda Breakdown of academic impact, for papers by Nitya Nathwani Breakdown of academic impact, for papers by Manabu Narisawa
Rankless by CCL
2026